Crystalline (2S)-3-(3S,4S)-3-(1R)-1- hydroxyethyl-4-(4-methoxy-3-{1-(5- methylpyridin-2-yl)azetidin-3-yloxy}phenyl)-3- methylpyrrolidin-1-yl-3-oxopropane-1,2-diol

摘要

The invention provides crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{[1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol, and pharmaceutical compositions thereof. The invention further provides methods of using this compound to treat overactive bladder.